辐射增强的CD24膜贩运通过GPI定介质 介质 抗瘤免疫逃避
Lingyi Kong1, Minqi Zhou1, Wenqian Yuan1
1Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei China.
Cancer research
|January 9, 2026
概括
受辐射的癌细胞使用ANAPC5/GPAA1轴增加CD24,一个"不要吃我"信号,导致免疫规避. 阻断GPAA1或CD24可以增强放射治疗效果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症研究 癌症研究
背景情况:
- 放射治疗是一种关键的癌症治疗方法,具有公认的免疫刺激作用.
- 了解辐射后的免疫逃生机制对于克服放射电阻至关重要.
研究的目的:
- 阐明瘤细胞在放射治疗后逃避免疫检测的机制.
- 确定提高放射治疗疗效的新目标.
主要方法:
- 在辐射瘤细胞中研究了ANAPC5/GPAA1轴.
- 评估了GPAA1和CD24在细胞抵抗和免疫逃避中的作用.
- 利用临床前癌症模型来评估GPAA1或CD24切除对放射治疗结果的影响.
- 检查了T细胞和巨细胞在观察到的影响中的参与.
主要成果:
- 被辐射的瘤细胞通过ANAPC5 / GPAA1轴上调表面CD24,促进免疫逃避.
- 辐射抑制APC/C复合体,导致GPAA1无处不在的减少和GPAA1积累的增加.
- GPAA1的积累增强了CD24膜的局部化,有助于对细胞酶的抗性.
- 切除GPAA1或CD24显著改善了放射治疗的局部抗瘤作用,这取决于T细胞和巨细胞.
- 缺少CD24也诱导了abscopal效应,抑制了非辐射瘤的生长.
结论:
- 确定了一种新的放射治疗诱导的免疫逃逸机制,涉及到ANAPC5 / GPAA1 / CD24轴.
- 证明向GPAA1或CD24可以通过恢复抗瘤免疫力来提高放射治疗的疗效.
- 这些发现为克服放射电阻和改善癌症治疗结果提供了潜在的策略.
更多相关视频
相关概念视频
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
02:17The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
01:35Cancer Cell Migration through Invadopodia
3.2K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.2K
02:30Metastasis
6.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K
01:15Receptor Downregulation in MVBs
2.8K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.8K